AFJK - Aimei Health Techno... Stock Analysis | Stock Taper
Logo
Aimei Health Technology Co., Ltd

AFJK

Aimei Health Technology Co., Ltd NASDAQ
$42.00 1.16% (+0.48)

Market Cap $257.11 M
52w High $130.37
52w Low $6.75
P/E 247.06
Volume 2.22K
Outstanding Shares 6.12M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $0 $250.59K $98.12K 0% $0.02 $-250.59K
Q3-2025 $0 $130.15K $352.02K 0% $0.06 $-130.15K
Q2-2025 $0 $41.6K $424.97K 0% $0.07 $-41.6K
Q1-2025 $0 $413.41K $184.66K 0% $0.02 $-413.41K
Q4-2024 $0 $402.02K $444.11K 0% $0.05 $444.11K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $2.93K $12.1M $4.06M $8.04M
Q3-2025 $2.98K $45.47M $3.46M $42M
Q2-2025 $2.14K $44.56M $2.9M $41.65M
Q1-2025 $7.34K $43.6M $2.38M $41.23M
Q4-2024 $28.21K $73.81M $1.51M $72.31M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $98.12K $-43.23K $33.69M $-33.65M $-50 $-43.23K
Q3-2025 $352.02K $-96.11K $-450K $546.95K $841 $-96.11K
Q2-2025 $424.97K $-201.75K $-450K $646.54K $-5.21K $-201.75K
Q1-2025 $184.66K $-224.01K $30.79M $-30.58M $-20.86K $-224.01K
Q4-2024 $444.11K $-195.13K $-277.7K $397.48K $-75.35K $-195.13K

5-Year Trend Analysis

A comprehensive look at Aimei Health Technology Co., Ltd's financial evolution and strategic trajectory over the past five years.

+ Strengths

AFJK currently benefits from a simple, debt-free capital structure and access to public equity markets, while United Hydrogen brings an integrated hydrogen ecosystem, early positioning in an important growth market, diverse end-use applications, and a strong emphasis on innovation and partnerships. Together, they create a platform that could tap into multiple aspects of the energy transition if the merger proceeds as planned.

! Risks

Key risks include AFJK’s lack of an operating business today, negative equity, and tight liquidity, as well as the heavy reliance on non-operating items for reported profit. On the operating side, United Hydrogen faces substantial execution, capital, technology, and policy risks in a volatile sector, compounded by the usual uncertainties around SPAC mergers, integration, market perception, and the need for ongoing funding to support large projects.

Outlook

The near-term financial statements of AFJK are not very informative about long-term economics; the real outlook depends on whether the United Hydrogen merger closes and how effectively that business scales. If policy support for hydrogen remains strong and the company can deliver on its integrated, innovation-led strategy, growth potential is significant, but so is the uncertainty, with outcomes likely to vary widely depending on execution and external conditions.